Navigation Links
ASTRO participates in FDA meeting on radiation safety
Date:6/16/2010

The American Society for Radiation Oncology (ASTRO) continued to advance its Target Safely initiative by participating in the Food and Drug Administration's (FDA) public meeting on Device Improvements to Reduce the Number of Under-Doses, Over-Doses, and Misaligned Exposures from Therapeutic Radiation on June 9 and 10. ASTRO commends the FDA on holding this meeting to identify current issues and further develop data, which will help inform the FDA's actions to ensure the highest level of safety for radiation therapy patients.

Numerous experts from the radiation therapy community, including those from clinical practice, academia and the device industry, gathered to address safety in radiation therapy. Meeting sessions looked at specific issues with device improvements and reporting, user training, and quality assurance. Eight ASTRO members, Lawrence Marks, M.D., Bruce Thomadsen, Ph.D., Todd Pawlicki, Ph.D., Eleanor Harris, M.D., Jeff Michalski, M.D., M.B.A., Prabhakar Tripuraneni, M.D., FASTRO, Eric Ford, Ph.D., and Benedick Fraass, Ph.D., FASTRO, gave presentations discussing the potential benefits of enhanced collaboration between device users and industry to improve usability, adding safety features to improve radiotherapy devices, and the need for a national medical event reporting system for radiotherapy administrations.

Presenters addressed challenges in keeping quality assurance protocols aligned with advances in technology, while acknowledging the important role that new technology can play in supporting quality assurance.


'/>"/>

Contact: Nicole Napoli
nicolen@astro.org
703-839-7336
American Society for Radiation Oncology
Source:Eurekalert

Page: 1

Related medicine news :

1. ASTRO, ACR issue IGRT, SBRT guidelines
2. Astronaut Balancing Act: Training to Help Explorers Adapt to a Return to Gravity
3. 5,000 deaths: A catastrophic, regrettable decision in Belgium
4. Does Glutathione-S-transferase associate with gastrointestinal cancer in Korean population?
5. Why does percutaneous endoscopic gastrostomy fail to eliminate gastroesophageal reflux?
6. Senate Committee Advances Disastrous Idaho Health Freedom Act
7. ReportsandReports : The Gastrointestinal Market Outlook to 2014: Market Dynamics, Competitive Landscape, Emerging Therapies
8. ASTRO awards 17 Advocacy Day travel grants
9. ASTRO publishes supplement on protecting cancer patients by reducing radiation doses, side effects
10. Santa Monica Jury Rejects Claims of Catastrophic Brain Injury From Exposure to Mold; Plaintiff Faces Motions for Attorney Fees and Costs
11. Astrogenetix Narrows in on MRSA Virulence Onboard Discovery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of indulgence ... high can result in disappointment, perhaps even self-loathing. However, those who set the bar ... from PsychTests.com reveals that behind the tendency to set low expectations is ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
(Date:6/23/2016)... BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a ... second affiliate in Latin America . ... ... ... ...
(Date:6/23/2016)... , June 23, 2016  Experian ... integrating and transforming the patient payment and ... several innovative new products and services that ... its revenue cycle offerings. These award-winning solutions ... efficient workflows, remain compliant in an ever-changing ...
Breaking Medicine Technology: